Margaret ("Peggy") A. Goodell (born March 23, 1965) is an American scientist working in the field of stem cell research. Dr. Goodell is Chair of the Department of Molecular and Cellular Biology at Baylor College of Medicine, Director of the Stem Cell and Regenerative Medicine (STaR) Center, a member of the National Academy of Medicine and the National Academy of Sciences. She is best known for her contributions to understanding how blood stem cells are regulated. Goodell has been on the faculty of Baylor College of Medicine since 1997 as a member of the Center for Cell and Gene Therapy, and the Departments of Pediatrics, Molecular and Human Genetics, and Molecular and Cellular Biology. She is the director of the Stem Cells and Regenerative Medicine Center, and is the Chair of the Department of Molecular and Cellular Biology. She holds the Thomas C Thompson Chair in Cell Biology, is the Co-Leader of the Cancer Cell and Gene Therapy program, and the Deputy Director for Basic Science at the Dan L. Duncan Comprehensive Cancer Center. She has received numerous awards for excellence in teaching and research. Goodell has served as chair of the scientific advisory board of the Keystone Symposia, as a former president of the International Society for Experimental Hematology, and on the board of the International Society for Stem Cell Research. She has also served for the American Society of Hematology, including as the chair of Stem Cells and Regenerative Medicine and as an Associate Editor for Blood, and she serves on the editorial boards of Cell Stem Cell and Cancer Cell.
Education Goodell began her education at Wesleyan University and moved on to the Imperial College of Science and Technology in London, England, for her final years, where she received her B.Sc. in Biochemistry with Honors in 1986. She went on to earn her Ph.D. at the University of Cambridge in 1991, working at the famous Laboratory of Molecular Biology. She returned to the United States to complete postdoctoral fellowships in Richard Mulligan’s lab at the Whitehead Institute for Biomedical Research at Massachusetts Institute of Technology and Harvard Medical School. At MIT, she developed a novel method for isolating blood-forming stem cells from mouse bone marrow based on a fortuitous observation that stem cells efflux fluorescent lipophilic dyes. This "side population (SP)" method became widely used to isolate stem cells from a variety of species and adult tissues, including from cancer stem cells.
… excerpt ends here. Continue reading the full article.


